Market Research Logo

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application, By Region (North America, APAC, Europe), And Segment Forecasts, 2018 - 2025

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application, By Region (North America, APAC, Europe), And Segment Forecasts, 2018 - 2025

The global radiopharmaceuticals/nuclear medicine market size is expected to reach USD 15.2 billion by 2025, according to a new report by Grand View Research, Inc., registering a 10.1% CAGR during the forecast period. The burden of chronic diseases such as cancer and cardiac disorders is on a rise. Nuclear medicine is widely used for diagnosis as well as treatment of such disorders.

Increasing prevalence of these disorders has a direct impact on usage of radiopharmaceuticals. As per data published by the World Health Organization (WHO), cancer is the second leading cause of death around the globe and in 2015, accounted for 8.8 million deaths. This is anticipated to drive demand for radiopharmaceuticals in the years to come.

Diagnostics, when combined with nuclear medicine, improve accuracy to a great extent. This can have a direct impact on decision-making and treatment monitoring processes. Adoption of PET as a diagnostic tool is rapidly increasing since it has shown greater precision over other diagnostic techniques.

Further key findings from the report suggest:

  • By product, the nuclear medicine market was dominated by the diagnostic segment in 2015, driven primarily by advancements in scanning technologies
  • The therapeutic segment, which comprises alpha emitters, beta emitters, and brachytherapy, is anticipated to exhibit lucrative growth over the coming years
  • On the basis of application, diagnostic formed the largest segment in 2015, including key areas such as cardiology, neurology, oncology, and thyroid
  • North America dominated the global radiopharmaceuticals market in 2015 owing to well-planned policies, favorable reimbursement structure, high healthcare spending, and increasing awareness
  • Asia Pacific is expected to witness lucrative growth in the coming years. Increasing per capita income and reform in policies is attracting market players
  • Key players in the industry include Eckert & Ziegler Group; Mallinckrodt Pharmaceuticals; GE Healthcare; Jubilant Life Sciences; Bracco Imaging S.p.A; and Nordion, Inc.


Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Scope And Assumptions
1.3 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
Chapter 4 Market Definitions
Chapter 5 Industry Outlook
5.1 Market Variable Analysis
5.1.1 Rising Incidence Of Cancer And Cardiovascular Disease
5.1.2 Widening Applications Of Radiopharmaceuticals
5.1.3 Growing Demand For The Accurate Diagnostic Methods
5.2 Market Restraint Analysis
5.2.1 Stringent Regulation For Production, Storage, And Usage
5.2.2 High Cost Involved With Diagnostics And Therapeutic Procedures
Chapter 6 Business Environment Aanalysis
6.1 SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
6.2 Porter’s Five Forces Analysis
6.3 Value Chain Analysis
Chapter 7 Regulatory And Political Forces
7.1 Regulatory Landscape
7.1.1 List Of Factors/ Regulations By Country
7.1.1.1 North America
7.1.1.1.1 U.S.
7.1.1.1.2 Canada
7.1.1.2 Europe
7.1.1.3 Asia Pacific
7.1.1.3.1 China
7.1.1.3.2 Japan
7.1.1.3.3 India
7.1.1.3.4 Australia/New Zealand
7.1.1.3.5 Korea
7.1.1.3.6 Singapore
7.1.1.3.7 Malaysia
7.1.1.3.8 Philippines
7.1.1.4 Middle East & Africa
7.1.1.4.1 South Africa
7.1.1.4.2 Gcc
7.1.1.5 Latin America
7.1.1.5.1 Brazil
7.1.1.5.2 Mexico
7.1.1.5.3 Argentina
7.2 Production Process And Trends
7.2.1 Production Process And Trends
7.2.1.1 Production Of Mo - 99 (SPECT Radioisotopes)
7.2.1.2 SPECT Radioisotopes Trends
7.2.1.3 PET Radioisotopes Trends
7.2.1.4 Therapeutic Radioisotopes Trends
7.2.1.5 Latest Developments
Chapter 8 Product Business Analysis
8.1 Radiopharmaceuticals Market: Product Movement Analysis
8.1.1 Diagnostic Products
8.1.1.1 Diagnostic Products Market, 2013 - 2025 (USD Million)
8.1.1.2 SPECT
8.1.1.3 SPECT Products Market, 2013 - 2025 (USD Million)
8.1.1.4 TC - 99m
8.1.1.4.1 TC - 99m Market, 2013 - 2025 (USD Million)
8.1.1.5 TL - 201
8.1.1.5.1 TL - 201 Market, 2013 - 2025 (USD Million)
8.1.1.6 GA - 67
8.1.1.6.1 GA - 67 Market, 2013 - 2025 (USD Million)
8.1.1.7 I - 123
8.1.1.7.1 I - 123 Market, 2013 - 2025 (USD Million)
8.1.1.8 Other SPECT Products
8.1.1.8.1 Other SPECT Products Market, 2013 - 2025 (USD Million)
8.1.1.9 PET
8.1.1.10 PET Products Market, 2013 - 2025 (USD Million)
8.1.1.11 F - 18
8.1.1.11.1 F - 18 Market, 2013 - 2025 (USD Million)
8.1.1.12 SR - 82/RB - 82
8.1.1.12.1 SR - 82/RB - 82 Market, 2013 - 2025 (USD Million)
8.1.1.13 Other PET Products
8.1.1.13.1 Other PET Products Market, 2013 - 2025 (USD Million)
8.1.1.2 Therapeutic Products
8.1.1.2.1 Therapeutic Products Market, 2013 - 2025 (USD Million)
8.1.1.2.2 Alpha Emitters
8.1.1.2.3 Alpha Emitters Market, 2013 - 2025 (USD Million)
8.1.1.2.4 RA - 223
8.1.1.2.4.1 RA - 223 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.5 Other Alpha Emitters
8.1.1.2.5.1 Other Alpha Emitters Market, 2013 - 2025 (USD Million)
8.1.1.2.1.6 Beta Emitters
8.1.1.2.1.7 Beta Emitters Market, 2013 - 2025 (USD Million)
8.1.1.2.1.8 I - 131
8.1.1.2.8.1 I - 131 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.9 Y - 90
8.1.1.2.9.1 Y - 90 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.10 SM - 153
8.1.1.2.10.1 SM - 153 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.11 Re - 186
8.1.1.2.11.1 Re - 186 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.12 Lu - 117
8.1.1.2.12.1 Lu - 177 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.13 Other Beta Emitters
8.1.1.2.13.1 Other Beta Emitters Market, 2013 - 2025 (USD Million)
8.1.1.2.1.14 Brachytherapy
8.1.1.2.1.15 Brachytherapy Market, 2013 - 2025 (USD Million)
8.1.1.2.1.16 Cesium - 131
8.1.1.2.16.1 Cesium - 131 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.17 Iodine - 125
8.1.1.2.17.1 Iodine - 125 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.18 Palladium - 103
8.1.1.2.18.1 Palladium - 103 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.19 Iridium - 192
8.1.1.2.19.1 Iridium - 192 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.20 Other Brachytherapy Products
8.1.1.2.20.1 Other Brachytherapy Products Market, 2013 - 2025 (USD Million)
Chapter 9 Application Mode Business Analysis
9.1 Radiopharmaceuticals Market: Application Movement Analysis.
9.1.1 Diagnostic Application
9.1.1.1 Diagnostic Application Market, 2013 - 2025 (USD Million)
9.1.1.2 Cardiology
9.1.1.3 Cardiology Applications Market, 2013 - 2025 (USD Million)
9.1.1.4 Neurology
9.1.1.5 Neurology Applications Market, 2013 - 2025 (USD Million)
9.1.1.6 Oncology
9.1.1.7 Oncology Applications Market, 2013 - 2025 (USD Million)
9.1.1.8 Thyroid
9.1.1.9 Thyroid Applications Market, 2013 - 2025 (USD Million)
9.1.1.10 Lymphoma
9.1.1.11 Lymphoma Applications Market, 2013 - 2025 (USD Million)
9.1.1.12 Other Diagnostic Application
9.1.1.13 Other Diagnostic Applications Market, 2013 - 2025 (USD Million)
9.1.2 Therapeutic Application
9.1.2.1 Therapeutic Application Market, 2013 - 2025 (USD Million)
9.1.2.2 Thyroid
9.1.2.3 Thyroid Applications Market, 2013 - 2025 (USD Million)
9.1.2.4 Bone Metastasis
9.1.2.5 Bone Metastasis Applications Market, 2013 - 2025 (USD Million)
9.1.2.6 Lymphoma
9.1.2.7 Lymphoma Applications Market, 2013 - 2025 (USD Million)
9.1.2.8 Endocrine Tumor
9.1.2.9 Endocrine Tumor Market, 2013 - 2025 (USD Million)
9.1.2.10 Other Therapeutic Application
9.1.2.11 Other Therapeutic Applications Market, 2013 - 2025 (USD Million)
Chapter 10 Regional Business Analysis
10.1 Radiopharmaceuticals Market: Regional Movement Analysis
10.1.1 North America
10.1.1.1 North America Market Estimates And Forecast, 2013 - 2025
10.1.1.2 U.S.
10.1.1.2.1 U.S. Market Estimates And Forecast, 2013 - 2025
10.1.1.3 Canada
10.1.1.3.1 Canada Market Estimates And Forecast, 2013 - 2025
10.1.2 Europe
10.1.2.1 Europe Market Estimates And Forecast, 2013 - 2025
10.1.2.2 Germany
10.1.2.2.1 Germany Market Estimates And Forecast, 2013 - 2025
10.1.2.3 U.K.
10.1.2.3.1 U.K. Market Estimates And Forecast, 2013 - 2025
10.1.2.4 France
10.1.2.4.1 France Market Estimates And Forecast, 2014 - 2025
10.1.2.5 Italy
10.1.2.5.1 Italy Market Estimates And Forecast, 2013 - 2025
10.1.2.6 Spain
10.1.2.6.1 Spain Market Estimates And Forecast, 2013 - 2025
10.1.2.7 Russia
10.1.2.7.1 Russia Market Estimates And Forecast, 2013 - 2025
10.1.2.8 Netherlands
10.1.2.8.1 Netherlands Market Estimates And Forecast, 2013 - 2025
10.1.3 Asia Pacific
10.1.3.1 Asia Pacific Market Estimates And Forecast, 2013 - 2025
10.1.3.2 Japan
10.1.3.2.1 Japan Market Estimates And Forecast, 2013 - 2025
10.1.3.3 China.
10.1.3.3.1 China Market Estimates And Forecast, 2013 - 2025
10.1.3.1.4 India
10.1.3.1.4.1 India Market Estimates And Forecast, 2014 - 2025
10.1.3.1.5 Australia
10.1.3.1.5.1 Australia Market Estimates And Forecast, 2013 - 2025
10.1.3.1.6 Singapore
10.1.3.1.6.1 Singapore Market Estimates And Forecast, 2014 - 2025
10.1.3.1.7 Malaysia
10.1.3.1.7.1 Malaysia Market Estimates And Forecast, 2013 - 2025
10.1.3.1.8 New Zealand
10.1.3.1.8.1 New Zealand Market Estimates And Forecast, 2013 - 2025
10.1.3.1.9 Korea
10.1.3.1.9.1 Korea Market Estimates And Forecast, 2013 - 2025
10.1.3.1.10 Philippines
10.1.3.1.10.1 Philippines Market Estimates And Forecast, 2013 - 2025
10.1.4 Latin America
10.1.4.1 Latin America Market Estimates And Forecast, 2013 - 2025
10.1.4.2 Brazil
10.1.4.2.1 Brazil Market Estimates And Forecast, 2013 - 2025
10.1.4.3 Mexico
10.1.4.3.1 Mexico Market Estimates And Forecast, 2013 - 2025
10.1.4.4 Argentina
10.1.4.4.1 Argentina Market Estimates And Forecast, 2013 - 2025
10.1.5 Middle East & Africa
10.1.5.1 Middle - East And Africa Market Estimates And Forecast, 2013 - 2025
10.1.5.2 Saudi Arabia
10.1.5.2.1 Saudi Arabia Market Estimates And Forecast, 2013 - 2025
10.1.5.3 South Africa
10.1.5.3.1 South Africa Market Estimates And Forecast, 2013 - 2025
10.1.5.4 Israel
10.1.5.4.1 Israel Market Estimates And Forecast, 2013 - 2025
10.1.5.1.5 Turkey
10.1.5.5.1 Turkey Market Estimates And Forecast, 2013 - 2025
Chapter 11 Company Profile
11.1 Eckert & Ziegler Group
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 Mallinckrodt
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 GE Healthcare
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.4 Jubilant Life Sciences Ltd.
11.4.1 Company Overview
11.4.2 Financial Performance
11.4.3 Product Benchmarking
11.4.4 Strategic Initiatives
11.5 Bracco Imaging S.P.A
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 Product Benchmarking
11.5.4 Strategic Initiatives
11.6 Nordion, Inc.
11.6.1 Company Overview
11.6.2 Financial Performance
11.6.3 Product Benchmarking
11.6.4 Strategic Initiatives
11.7 The Institute For Radioelements (IRE)
11.7.1 Company Overview
11.7.2 Financial Performance
11.7.3 Product Benchmarking
11.7.4 Strategic Initiatives
11.8 Australian Nuclear Science & Technology Organization (ANSTO)
11.8.1 Company Overview
11.8.2 Financial Performance
11.8.3 Product Benchmarking
11.9 NTP Radioisotopes SOC Ltd.
11.9.1 Company Overview
11.9.2 Financial Performance
11.9.3 Product Benchmarking
11.9.4 Strategic Initiatives
11.10 Eczacibasi - Monrol
11.10.1 Company Overview
11.10.2 Financial Performance
11.10.3 Product Benchmarking
Chapter 12 KOL Commentary
12.1 Key Insights
12.2 KOL Views
Chapter 13 Recommendations
List of Tables
Table 1 List of Abbreviation
Table 2 North America nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 3 North America diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 4 North America SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 5 North America PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 6 North America therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 7 North America alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 8 North America beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 9 North America brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 10 North America nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 11 North America diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 12 North America therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 13 U.S. nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 14 U.S. diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 15 U.S. SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 16 U.S. PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 17 U.S. therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 18 U.S. alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 19 U.S. beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 20 U.S. brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 21 U.S. nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 22 U.S. diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 23 U.S. therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 24 Canada nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 25 Canada diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 26 Canada SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 27 Canada PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 28 Canada therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 29 Canada alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 30 Canada beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 31 Canada brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 32 Canada nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 33 Canada diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 34 Canada therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 35 Europe nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 36 Europe diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 37 Europe SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 38 Europe PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 39 Europe therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 40 Europe alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 41 Europe beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 42 Europe brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 43 Europe nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 44 Europe diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 45 Europe therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 46 Germany nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 47 Germany diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 48 Germany SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 49 Germany PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 50 Germany therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 51 Germany alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 52 Germany beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 53 Germany brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 54 Germany nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 55 Germany diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 56 Germany therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 57 U.K. nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 58 U.K. diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 59 U.K. SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 60 U.K. PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 61 U.K. therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 62 U.K. alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 63 U.K. beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 64 U.K. brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 65 U.K. nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 66 U.K. diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 67 U.K. therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 68 France nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 69 France diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 70 France SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 71 France PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 72 France therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 73 France alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 74 France beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 75 France brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 76 France nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 77 France diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 78 France therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 79 Italy nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 80 Italy diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 81 Italy SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 82 Italy PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 83 Italy therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 84 Italy alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 85 Italy beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 86 Italy brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 87 Italy nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 88 Italy diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 89 Italy therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 90 Spain nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 91 Spain diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 92 Spain SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 93 Spain PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 94 Spain therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 95 Spain alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 96 Spain beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 97 Spain brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 98 Spain nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 99 Spain diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 100 Spain therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 101 Russia nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 102 Russia diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 103 Russia SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 104 Russia PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 105 Russia therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 106 Russia alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 107 Russia beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 108 Russia brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 109 Russia nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 110 Russia diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 111 Russia therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 112 Netherlands nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 113 Netherlands diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 114 Netherlands SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 115 Netherlands PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 116 Netherlands therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 117 Netherlands alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 118 Netherlands beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 119 Netherlands brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 120 Netherlands nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 121 Netherlands diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 122 Netherlands therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 123 Asia Pacific nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 124 Asia Pacific diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 125 Asia Pacific SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 126 Asia Pacific PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 127 Asia Pacific therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 128 Asia Pacific alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 129 Asia Pacific beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 130 Asia Pacific brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 131 Asia Pacific nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 132 Asia Pacific diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 133 Asia Pacific therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 134 Japan nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 135 Japan diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 136 Japan SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 137 Japan PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 138 Japan therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 139 Japan alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 140 Japan beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 141 Japan brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 142 Japan nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 143 Japan diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 144 Japan therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 145 China nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 146 China diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 147 China SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 148 China PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 149 China therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 150 China alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 151 China beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 152 China brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 153 China nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 154 China diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 155 China therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 156 Latin America nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 157 India diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 158 India SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 159 India PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 160 India therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 161 India alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 162 India beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 163 India brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 164 India nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 165 India diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 166 India therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 167 Australia nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 168 Australia diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 169 Australia SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 170 Australia PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 171 Australia therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 172 Australia alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 173 Australia beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 174 Australia brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 175 Australia nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 176 Australia diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 177 Australia therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 178 Singapore nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 179 Singapore diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 180 Singapore SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 181 Singapore PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 182 Singapore therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 183 Singapore alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 184 Singapore beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 185 Singapore brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 186 Singapore nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 187 Singapore diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 188 Singapore therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 189 Malaysia nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 190 Malaysia diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 191 Malaysia SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 192 Malaysia PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 193 Malaysia therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 194 Malaysia alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 195 Malaysia beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 196 Malaysia brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 197 Malaysia nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
Table 198 Malaysia diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 199 Malaysia therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
Table 200 New Zealand nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 201 New Zealand diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 202 New Zealand SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
Table 203 New Zealand PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
Table 204 New Zealand therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report